The startup develops guidewire-free extended dwell catheters designed to reduce the frequency of needle sticks for blood draws and IVs. This technology aims to improve patient comfort, enhance clinical outcomes, and lower healthcare provider costs by offering a more reliable vascular access solution.
Funding
Funding not disclosed
Founders
Product
Problem
Repeated needle sticks for blood draws and intravenous (IV) therapy can cause patient discomfort, increase the risk of complications such as infections and hematomas, and consume valuable healthcare provider time. Traditional catheters often require guidewires for insertion, adding complexity and potential for insertion-related injuries.
Solution
This startup is developing guidewire-free extended dwell catheters designed to minimize the need for frequent venipunctures. The catheters are engineered for easier, less traumatic insertion, aiming to improve patient comfort and reduce the likelihood of vascular access complications. By providing a more reliable and less invasive method for accessing a patient's vasculature, the technology seeks to streamline workflows for healthcare professionals and lower overall healthcare costs associated with repeated IV insertions and blood draws.
Target Audience
The primary target audience includes hospitals, outpatient clinics, and long-term care facilities seeking to improve patient care and reduce costs associated with vascular access procedures.
Features
- Guidewire-free design for simplified insertion and reduced risk of vessel damage
- Extended dwell time to minimize the frequency of catheter replacements
- Biocompatible materials to reduce the risk of thrombophlebitis and other adverse reactions
- Integrated safety mechanisms to prevent accidental needle sticks and blood exposure